#tanujsircar — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #tanujsircar, aggregated by home.social.
-
Sanofi abandons eczema drug approval efforts in another blow to OX40 class
Sanofi has chosen not to file for approval or continue the development of its immunology therapy, amlitelimab, in…
#France #FR #Europe #EU #Sanofi #AD #blockbusterdrug #development #developmentprogramme #discontinuation #drugclass #GlobalData #marketprospects #TanujSircar
https://www.europesays.com/france/59964/